{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T04:42:06Z","timestamp":1773117726068,"version":"3.50.1"},"reference-count":33,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2006,4,4]],"date-time":"2006-04-04T00:00:00Z","timestamp":1144108800000},"content-version":"vor","delay-in-days":34,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pediatric Dermatology"],"published-print":{"date-parts":[[2006,3]]},"abstract":"<jats:p><jats:bold>Abstract:\u2002<\/jats:bold> Hemangiomas, common proliferative vascular tumors, can grow rapidly in the first months of life. Although therapy with high\u2010dose oral glucocorticoids is standard for lesions that threaten vital functions or are disfiguring, little is known about the endocrine consequences of this treatment. Using retrospective data, we examined growth velocity, changes in bone mineral density, and adrenal function in infants with hemangiomas treated with systemic glucocorticoids. Treatment consisted of oral prednisolone 2 to 4\u00a0mg\/kg\/day or dexamethasone 1\u00a0mg\/kg\/day. Mean growth velocity Z score on glucocorticoid therapy was \u22121.41 standard deviations in 13 patients. In four infants with adequate follow\u2010up, growth velocity increased to +1.90 standard deviations after glucocorticoid treatment (\u0394 growth velocity +3.31 standard deviations). Mean lumbar spine bone mineral density Z score was \u22122.46 standard deviations before glucocorticoid treatment and \u22121.08 standard deviations at the end of treatment in six infants. Adrenal function after glucocorticoid therapy was assessed by low\u2010dose adrenocorticotropic hormone stimulation test in 10 infants. Eight had a normal cortisol response, and one had a borderline response. One infant, who had been treated with dexamethasone, had an abnormal test result. In conclusion, systemic glucocorticoid treatment in infants with hemangiomas slowed linear growth, but \u201ccatch\u2010up\u201d growth was observed after treatment ceased. Glucocorticoids did not affect bone mineralization adversely. Only 1 of 10 glucocorticoid\u2010treated infants had clear evidence of adrenal insufficiency after therapy was stopped.<\/jats:p>","DOI":"10.1111\/j.1525-1470.2006.00207.x","type":"journal-article","created":{"date-parts":[[2006,4,4]],"date-time":"2006-04-04T16:02:54Z","timestamp":1144166574000},"page":"169-174","source":"Crossref","is-referenced-by-count":19,"title":["Growth, Bone Mineral Accretion, and Adrenal Function in Glucocorticoid\u2010Treated Infants with Hemangiomas \u2013 A Retrospective Study"],"prefix":"10.1111","volume":"23","author":[{"given":"Jefferson P.","family":"Lomenick","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philippe F.","family":"Backeljauw","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne W.","family":"Lucky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2006,4,4]]},"reference":[{"key":"e_1_2_5_2_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1651-2227.1955.tb04151.x"},{"key":"e_1_2_5_3_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1525-1470.1986.tb00535.x"},{"key":"e_1_2_5_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3468(83)80043-8"},{"key":"e_1_2_5_5_2","first-page":"2167","volume-title":"Nelson textbook of pediatrics.","author":"Darmstadt GL","year":"2004"},{"key":"e_1_2_5_6_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.137.9.1208"},{"key":"e_1_2_5_7_2","doi-asserted-by":"publisher","DOI":"10.1001\/archfaci.2.2.103"},{"key":"e_1_2_5_8_2","doi-asserted-by":"publisher","DOI":"10.1080\/088800101750059855"},{"key":"e_1_2_5_9_2","doi-asserted-by":"publisher","DOI":"10.1097\/00019616-199801000-00006"},{"key":"e_1_2_5_10_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM195604052541402"},{"key":"e_1_2_5_11_2","first-page":"207","article-title":"Growth retardation in Cushing's syndrome","volume":"123","author":"Strickland AL","year":"1972","journal-title":"Am J Dis Child"},{"key":"e_1_2_5_12_2","doi-asserted-by":"publisher","DOI":"10.1210\/en.136.1.209"},{"key":"e_1_2_5_13_2","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-61-4-618"},{"key":"e_1_2_5_14_2","doi-asserted-by":"crossref","first-page":"4776","DOI":"10.1210\/endo.136.11.7588206","article-title":"Transcriptional repression of IGF\u2010I by glucocorticoids in rat bone cells","volume":"136","author":"Delany AM","year":"1995","journal-title":"Endocrinology"},{"key":"e_1_2_5_15_2","first-page":"609","volume-title":"Williams textbook of endocrinology","author":"Orth DN","year":"1998"},{"key":"e_1_2_5_16_2","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-25-1-11"},{"key":"e_1_2_5_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(67)92592-5"},{"key":"e_1_2_5_18_2","first-page":"630","article-title":"Adrenal suppression after short\u2010term corticosteroid therapy","volume":"1","author":"Wilson AS","year":"1979","journal-title":"Lancet"},{"key":"e_1_2_5_19_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI109506"},{"key":"e_1_2_5_20_2","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-39-6-1151"},{"key":"e_1_2_5_21_2","doi-asserted-by":"publisher","DOI":"10.1002\/jcb.240570314"},{"key":"e_1_2_5_22_2","first-page":"913","volume-title":"The Harriet Lane handbook","author":"Sachdev S","year":"2002"},{"key":"e_1_2_5_23_2","first-page":"137","volume-title":"The diagnosis and treatment of endocrine disorders in childhood and adolescence.","author":"Tanner JM","year":"1994"},{"key":"e_1_2_5_24_2","doi-asserted-by":"publisher","DOI":"10.1159\/000023438"},{"key":"e_1_2_5_25_2","doi-asserted-by":"publisher","DOI":"10.1097\/00019616-199707050-00002"},{"key":"e_1_2_5_26_2","first-page":"499","volume-title":"Clinical paediatric endocrinology","author":"Forest MG","year":"1995"},{"key":"e_1_2_5_27_2","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-73-6-1332"},{"key":"e_1_2_5_28_2","doi-asserted-by":"publisher","DOI":"10.1097\/00006534-199911000-00002"},{"key":"e_1_2_5_29_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.140.8.963"},{"key":"e_1_2_5_30_2","doi-asserted-by":"publisher","DOI":"10.1136\/adc.80.4.330"},{"key":"e_1_2_5_31_2","doi-asserted-by":"publisher","DOI":"10.1148\/radiology.179.3.2027984"},{"key":"e_1_2_5_32_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa040367"},{"key":"e_1_2_5_33_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMe048193"},{"key":"e_1_2_5_34_2","first-page":"413","volume-title":"Pediatric endocrinology","author":"Miller WL","year":"2002"}],"container-title":["Pediatric Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1525-1470.2006.00207.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1525-1470.2006.00207.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,14]],"date-time":"2023-10-14T01:55:04Z","timestamp":1697248504000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1525-1470.2006.00207.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,3]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006,3]]}},"alternative-id":["10.1111\/j.1525-1470.2006.00207.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1525-1470.2006.00207.x","archive":["Portico"],"relation":{},"ISSN":["0736-8046","1525-1470"],"issn-type":[{"value":"0736-8046","type":"print"},{"value":"1525-1470","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,3]]}}}